Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide |
|
Author:
| Warsh, Cheryl Krasnick |
ISBN: | 978-0-19-763254-3 |
Publication Date: | May 2024 |
Publisher: | Oxford University Press, Incorporated
|
Book Format: | Hardback |
List Price: | USD $34.99 |
Book Description:
|
In the early 1960s, Dr. Frances Oldham Kelsey of the U.S. Food and Drug Administration became one of the most celebrated women in America when she prevented the deadly sedative thalidomide from entering the U.S. market. Her lifesaving work there became the basis for the FDA's current drug approval protocols. This biography brings to light the efforts and legacy of a pioneering woman in science whose contributions are still influential today.
In the early 1960s, Dr. Frances Oldham Kelsey of the U.S. Food and Drug Administration became one of the most celebrated women in America when she prevented the deadly sedative thalidomide from entering the U.S. market. Her lifesaving work there became the basis for the FDA's current drug approval protocols. This biography brings to light the efforts and legacy of a pioneering woman in science whose contributions are still influential today.